쎌바이오텍

049960KOSDAQ

63.9 / 100

Reference Date: 2026-09-08

Financial Score27.5 / 40

News Sentiment16.4 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Slightly up 1.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Sebaitech operates in three main areas: probiotics, microbiome, and anti-cancer drug development. It maintains the top position in South Korea's probiotic exports and is developing functional foods for atopic dermatitis and menopausal symptoms through its microbiome business. The company also aims to create probiotic-based therapies for ulcerative colitis and colorectal cancer.

Number of Employees

123people

Average Salary

45.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.64Industry Average 15.006.5Point

Lower than industry avg (good)

PBR

1.12Industry Average 1.204.0Point

In line with industry avg

ROE

7.92Industry Average 8.002.5Point

Below industry avg

Debt Ratio

0.06Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼0.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲113.0% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.8% (improving, 3yr)

Detailed News Sentiment

9 totalPositive 4Neutral 5Negative 0Average Sentiment Score 65.6

Neutral
소 없이 만든 ‘의성 한우’…우리 식탁엔 언제 오를까 [식탐]
The news discusses advancements in cell-based meat technology but does not directly impact 쎌바이오텍's specific stock performance.
Positive
"고기부터 작물·유산균까지"…K-바이오푸드, 식량 선택지 넓힌다
K-바이오푸드의 혁신적인 기술 도입으로 쎌바이오텍과 관련 산업의 식량 선택지 확대 및 기술적 성장 기대.
Positive
바이오협회, 식량위기 3대 축 제시…"2031년 그린바이오 10조 시장...
쎌바이오텍은 배양육 기술 상용화와 함께 그린바이오 분야에서의 성장 잠재력을 보여주며 긍정적인 전망을 받고 있다.

Detailed Momentum

52-week position6.0Point

52w upper range (64%)

Current 15,740Won52-week high 18,11052-week low 11,500

1-month return3.0Point

1m 1.16% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14